We read with great interest a recent review by [@r8] and would like to add some comments to facilitating effects of particulate matter (PM) on preexisting respiratory diseases. First of all, the adverse effects of PM/diesel exhaust particles (DEP) on chronic obstructive pulmonary disease (COPD) pathophysiology seem to be controversial. Subjects with pulmonary emphysema are epidemiologically susceptible to PM ([@r2]; [@r3]; [@r7]; [@r10]). Further, as noted by [@r8], [@r6] have experimentally shown that chronic (2 months) exposure to an ambient level (mean concentration, 34 µg/m^3^) of PM~10~ (PM \< 10 µm in aerodynamic diameter) worsens murine emphysema induced by papain. In contrast, in our previous study ([@r4]) we did not obtain apparent evidence that a single intratracheal administration of DEP \[200 µg/animal, a dose high enough to worsen infectious lung injury ([@r9])\] exacerbates porcine pancreatic elastase--elicited pulmonary emphysema in mice. Possible explanations for this opposite phenomenon may include differences in animal strains or species, pathological conditions (type and/or  degree of emphysematous inflammation), and/or DEP exposure protocols (route, dose, timing, duration, and/or terminal point). Additional in-depth studies will be required to conclude PM/DEP has adverse effects on COPD pathophysiology.

Secondly, from a biological point of view, pulmonary fibrosis (PF) should be added to the list of PM-susceptible respiratory diseases. Recently, [@r1] showed that exposure to carbon black nanoparticles exacerbates bleomycin-induced PF in mice. More recently, we demonstrated that a single intratracheal instillation of tiny carbon black nanoparticles (14 nm) at a dose of 10 µg/mouse aggravates PF, suggesting that exposure to trace amounts of PM can exacerbate pathophysiology ([@r5]). Accordingly, careful attention should be paid to PF patients who are at risk of environmental and occupational exposure to PM, although further basic and clinical research is necessary.
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[^1]: Editor's note: In accordance with journal policy, Sacks et al. were asked whether they wanted to respond to this letter, but they chose not to do so.
